These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16499499)

  • 1. Understanding and treating alcohol dependence.
    Johnson BA; Koob GF; Schuckit MA; Mason BJ; Ait-Daoud N
    Alcohol Clin Exp Res; 2006 Mar; 30(3):567-84. PubMed ID: 16499499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics.
    Johnson BA; Swift RM; Ait-Daoud N; DiClemente CC; Javors MA; Malcolm RJ
    Alcohol Clin Exp Res; 2004 Feb; 28(2):295-301. PubMed ID: 15112937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid alcohol and nicotine dependence: from the biomolecular basis to clinical consequences.
    Ait-Daoud N; Wiesbeck GA; Bienkowski P; Li MD; Pfützer RH; Singer MV; Lesch OM; Johnson BA
    Alcohol Clin Exp Res; 2005 Aug; 29(8):1541-9. PubMed ID: 16156051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of GABAergic medications for treating alcoholism.
    Johnson BA; Swift RM; Addolorato G; Ciraulo DA; Myrick H
    Alcohol Clin Exp Res; 2005 Feb; 29(2):248-54. PubMed ID: 15714047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry.
    Johnson BA; Mann K; Willenbring ML; Litten RZ; Swift RM; Lesch OM; Berglund M
    Alcohol Clin Exp Res; 2005 Aug; 29(8):1528-40. PubMed ID: 16156050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of craving in alcohol use, dependence, and treatment.
    Flannery BA; Roberts AJ; Cooney N; Swift RM; Anton RF; Rohsenow DJ
    Alcohol Clin Exp Res; 2001 Feb; 25(2):299-308. PubMed ID: 11236847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential neuroprotective effects of acamprosate.
    Koob GF; Mason BJ; De Witte P; Littleton J; Siggins GR
    Alcohol Clin Exp Res; 2002 Apr; 26(4):586-92. PubMed ID: 11981137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of alcoholism using intermediate phenotypes.
    Enoch MA; Schuckit MA; Johnson BA; Goldman D
    Alcohol Clin Exp Res; 2003 Feb; 27(2):169-76. PubMed ID: 12605066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using acquired knowledge and new technologies in alcoholism treatment trials.
    Flannery BA; Allen JP; Pettinati HM; Rohsenow DJ; Cisler RA; Litten RZ
    Alcohol Clin Exp Res; 2002 Mar; 26(3):423-9. PubMed ID: 11923598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the pharmacotherapy of alcoholism: challenging misconceptions.
    Kranzler HR; Koob G; Gastfriend DR; Swift RM; Willenbring ML
    Alcohol Clin Exp Res; 2006 Feb; 30(2):272-81. PubMed ID: 16441276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current progress in pharmacologic treatment strategies for alcohol dependence.
    Clapp P
    Expert Rev Clin Pharmacol; 2012 Jul; 5(4):427-35. PubMed ID: 22943122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding and treating alcohol craving and dependence: recent pharmacological and neuroendocrinological findings.
    Leggio L
    Alcohol Alcohol; 2009; 44(4):341-52. PubMed ID: 19451661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validity of DSM-IV alcohol dependence: what do we know and what do we need to know?
    Hasin DS; Schuckit MA; Martin CS; Grant BF; Bucholz KK; Helzer JE
    Alcohol Clin Exp Res; 2003 Feb; 27(2):244-52. PubMed ID: 12605073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active ingredients: how and why evidence-based alcohol behavioral treatment interventions work.
    Longabaugh R; Donovan DM; Karno MP; McCrady BS; Morgenstern J; Tonigan JS
    Alcohol Clin Exp Res; 2005 Feb; 29(2):235-47. PubMed ID: 15714046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroscience: implications for treatment.
    Petrakis I; Krystal J
    Alcohol Health Res World; 1997; 21(2):157-60. PubMed ID: 15704353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-occurring alcohol and cocaine dependence: recent findings from clinical and field studies.
    Flanner BA; Morgenstern J; McKay J; Wechsberg WM; Litten RZ
    Alcohol Clin Exp Res; 2004 Jun; 28(6):976-81. PubMed ID: 15218883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The corticotropin-releasing factor/urocortin system and alcohol.
    Ryabinin AE; Bachtell RK; Heinrichs SC; Lee S; Rivier C; Olive MF; Mehmert KK; Camarini R; Kim JA; Koenig HN; Nannini MA; Hodge CW; Roberts AJ; Koob GF
    Alcohol Clin Exp Res; 2002 May; 26(5):714-22. PubMed ID: 12045481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical and clinical studies on naltrexone: what have they taught each other?
    Froehlich J; O'Malley S; Hyytiä P; Davidson D; Farren C
    Alcohol Clin Exp Res; 2003 Mar; 27(3):533-9. PubMed ID: 12658121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants.
    Ait-Daoud N; Malcolm RJ; Johnson BA
    Addict Behav; 2006 Sep; 31(9):1628-49. PubMed ID: 16472931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of alcohol abuse: an evidence-based review.
    Berglund M; Thelander S; Salaspuro M; Franck J; Andréasson S; Ojehagen A
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1645-56. PubMed ID: 14574236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.